Identification of antidepressant constituents from Xiangfu-chuanxiong herbal medicine pair via spectrum-effect relationship analyses, molecular docking and corticosterone-induced PC12 cells

被引:3
作者
Li, Hui-jun [1 ]
Ye, Xiao-chuan [1 ]
Jia, Hong-mei [2 ]
Liu, Yang [2 ]
Yu, Meng [2 ]
Zou, Zhong-mei [1 ,2 ]
机构
[1] Hubei Univ Chinese Med, Sch Pharm, Hubei Key Lab Resources & Chem Chinese Med, Wuhan 430065, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, State Key Lab Basis & New Drug Dev Nat & Nucl Drug, Beijing 100193, Peoples R China
基金
中国国家自然科学基金;
关键词
Cyperi Rhizoma; Chuanxiong Rhizoma; Herbal medicine pair; Antidepressant; Z-ligustilide; INHIBITION; DEPRESSION;
D O I
10.1016/j.fitote.2024.106087
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herbal medicine pair, composed of two single herbs, is a relatively fixed minimum prescription unit in the traditional Chinese medicine's formula and has special significance in clinic. The combination of Xiangfu (the rhizoma of Cyperus rotundus L, XF) and Chuanxiong (the rhizoma of Ligusticum chuanxiong Hort, CX) has been recoded as an herbal medicine pair XF-CX in the Yuan Dynasty (1347 CE) of China and widely used in traditional Chinese medicine formula, including Chaihu Shugan San, which has been clinically used for treatment of depression. However, the optimal ratio of the XF-CX herbal medicine pair and its antidepressant constituents are still unclear. Herein, the antidepressive-like effects of XF-CX herbal medicine pairs with different ratios of XF and CX (2:1, 1:1, 1:2) were evaluated using behavioral despair animal models in mice, and then its potential antidepressant constituents were recognized by spectrum-effect relationship analyses. Finally, the potential antidepressant constituents of the XF-CX herbal medicine pair were validated by molecular docking with glucocorticoid receptor and corticosterone (CORT)-induced PC12 cell injury model. The results indicated that different ratios of XF-CX pairs had antidepressive-like effects, and the XF-CX (2:1) exhibited a more significant effect. Thirty-two potential antidepressant constituents in the XF-CX herbal medicine pair were screened out from the spectrumeffect relationship combined molecular docking analyses. Among them, senkyunolide A, cyperotundone, Z-ligustilide, and levistilide A were validated to have protective effects against CORT-induced injury in PC12 cells. Our findings not only obtained the optimal ratio of XF-CX in the herbal medicine pair for the treatment of depression but also its potential antidepressant constituents, which will benefit in elucidating the mechanism of action and promoting the application of the herbal medicine pair in the clinic.
引用
收藏
页数:8
相关论文
共 34 条
[1]   Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior [J].
Abe-Higuchi, Naoko ;
Uchida, Shusaku ;
Yamagata, Hirotaka ;
Higuchi, Fumihiro ;
Hobara, Teruyuki ;
Hara, Kumiko ;
Kobayashi, Ayumi ;
Watanabe, Yoshifumi .
BIOLOGICAL PSYCHIATRY, 2016, 80 (11) :815-826
[2]   The monoaminergic pathways are involved in the antidepressant-like effect of quercetin [J].
Adeoluwa, Olusegun Adebayo ;
Eduviere, Anthony Taghogho ;
Adeoluwa, Gladys Onyinye ;
Otomewo, Lily Oghenevovwero ;
Adeniyi, Funmilayo Racheal .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (04) :2497-2506
[3]   Synthesis and biological evaluation of novel naphthalene compounds as potential antidepressant agents [J].
Ang, Wei ;
Chen, Gong ;
Xiong, Li ;
Chang, Ying ;
Pi, Weiyi ;
Liu, Yuanyuan ;
Li, Chunlong ;
Zheng, Jiajia ;
Zhou, Liangxue ;
Yang, Bo ;
Deng, Yong ;
Yang, Shengyong ;
Luo, Youfu ;
Wei, Yuquan .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 82 :263-273
[4]   Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders [J].
Anisman, Hymie ;
Merali, Zul ;
Hayley, Shawn .
PROGRESS IN NEUROBIOLOGY, 2008, 85 (01) :1-74
[5]   Depressive symptoms in neurodegenerative diseases [J].
Baquero, Miquel ;
Martin, Nuria .
WORLD JOURNAL OF CLINICAL CASES, 2015, 3 (08) :682-693
[6]   Ferulic acid as a therapeutic agent in depression: Evidence from preclinical studies [J].
Dong, Xiaoyu ;
Zhao, Dongxue .
CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) :2397-2412
[7]   Neural plasticity to stress and antidepressant treatment [J].
Duman, RS ;
Malberg, J ;
Thome, J .
BIOLOGICAL PSYCHIATRY, 1999, 46 (09) :1181-1191
[8]   Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK38/PTEN/Akt pathway [J].
Fan, Qiqi ;
Liu, Yuanyue ;
Sheng, Lei ;
Lv, Shuang ;
Yang, Li ;
Zhang, Zhaoming ;
Guo, Jiaping ;
Fan, Yafei ;
Hu, Dan .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
[9]   Traditional Chinese Medicine for Cardiovascular Disease Evidence and Potential Mechanisms [J].
Hao, Panpan ;
Jiang, Fan ;
Cheng, Jing ;
Ma, Lianyue ;
Zhang, Yun ;
Zhao, Yuxia .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (24) :2952-2966
[10]   Digeda-4 decoction and its disassembled prescriptions improve dyslipidemia and apoptosis by regulating AMPK/SIRT1 pathway on tyloxapol-induced nonalcoholic fatty liver disease in mice [J].
Ji, Xiaoping ;
Ma, Qianqian ;
Wang, Xuan ;
Ming, Hui ;
Bao, Guihua ;
Fu, Minghai ;
Wei, Chengxi .
JOURNAL OF ETHNOPHARMACOLOGY, 2023, 317